Chlamydia test – Heiki Thu, 16 Sep 2021 02:36:35 +0000 en-US hourly 1 Chlamydia test – Heiki 32 32 Epidemiologist from the city of El Paso recognized by the LGBTQ + community Wed, 15 Sep 2021 23:22:12 +0000

EL PASO, Texas (KTSM) – City of El Paso public health epidemiologist Vanessa Casner has secured a spot on the LGBTQ + Playing Cards Border Heroes for her LGBTQ + advocacy and HIV awareness activism.

“I am honored to be recognized for the work we do at the Department of Public Health (DPH) for our LGBTQ + community in our efforts to ensure a thriving quality of life for all members of the community,” said Casner .

The Borderland Rainbow Center and the Diversity and Resiliency Institute of El Paso have created the Border Heroes Playing Card Deck Project to honor LGBTQ + leaders and influencers from the border, with work by artists from the border.

City officials share that the Ministry of Public Health provides a variety of inclusive health services for the community, including HIV prevention services, including:

  • LGBTQ + Cultural Sensitivity Training Education
  • Free testing for HIV, syphilis and hepatitis C
  • Housing support services for people living with HIV and homelessness
  • Free harm reduction counseling for people living with HIV and those at risk of becoming HIV positive
  • Mfactor El Paso, a social networking group for gay / bi and queer men, ages 18-39
  • Community mobilization, a community planning organization to support and improve HIV prevention and care services in El Paso
  • HIV support group
  • The purple pages of El Paso, an online resource for LGBTQ + friendly medical providers, social service providers and organizations
  • PrEP navigation services, free services to providers and clinics who can prescribe pre-exposure prophylaxis (PrEP) as well as financial assistance for the drug
  • Condom distribution services
  • References to services

For more information on HIV-related services, visit and click on the HIV Prevention tab. For more information on the Border Heroes project, visit

For our previous coverage of the LGBTQ + community, click here.

For local and breaking news, sports, weather alerts, videos and more, download the FREE KTSM 9 News app from the Apple App Store or the Google play store.

]]> 0
Finding Comfort For Gynecological Problems Sat, 11 Sep 2021 18:46:20 +0000

With female biology comes a number of challenges, especially when our hormones are skyrocketing at different stages of our lives. Listening to the signals our body is sending helps ward off major ailments.

Painful periods

Called dysmenorrhea, painful menstrual cycles are characterized by debilitating cramps in the lower abdomen and throbbing pain in the thighs. Often, the continuous dull ache makes you immobile, affecting the quality of life. Usually common during menarche, painful stab wounds can also be a common feature in older women.

A hot water bottle, targeted pain reliever for acute menstrual spasms, or even disposable strips for lower period pain relief work well. “Keeping your weight under control leads to many gynecological problems, such as irregular periods, painful cycles under control,” explains gynecologist Ashima Malik.

Vaginal discomfort

“A vaginal infection, or urinary tract infection, or a boil of the skin near the vulva (labia of the vagina) often causes vaginal discharge or itching,” says Dr Vaishali Joshi, a senior obstetrician and gynecologist based in Mumbai. “Over-the-counter medications usually don’t work because correct treatment by your gynecologist is needed to treat it,” she adds. It is important to maintain vaginal hygiene, but not always to shower after urinating, to protect the healthy bacteria in the area. Wear breathable cotton underwear, avoid skinny jeans and tummy control underwear that constrict the vagina, and change often to stay clean and dry in our humid tropical climates, she suggests.

Place below

According to Dr. Vaishalii, “Spotting after intercourse or even between menstrual cycles can be a warning sign of sexually transmitted infections (STIs), also known as pelvic inflammatory disease or cervical cancer or infection. uterus. Clear visualization of the lower genitals is required as well as specific tests such as a PAP test and a chlamydia test to make an accurate diagnosis. Remember that STIs and early cancer of the cervix (cervix) can be treated completely if caught early. Keep track of the spots, especially if you have symptoms of perimenopause.

a small leak

Often times when you laugh out loud, or suddenly, you feel a little trickle underneath. Especially if you hugged a full bladder during the trip. “Try Kegel exercises to strengthen the muscles below, as you tend to expel a little urine while coughing hard or sneezing violently,” suggests Dr. Ashima. Timely bladder training can help. Make sure that you are regular with Kegel exercises to strengthen the muscles after childbirth as well as to prevent the progression of the problem.

Go forward

Regular breast self-examination is a must for every woman. Often there are tiny nodules left behind from breast engorgement that you may have felt while breastfeeding.

“Constantly check the breasts for a lump or swelling, note any discharge and make an appointment with your gynecologist. Be regular with your Pap smear and mammogram after the age of 40, ”says Dr Ashima.

]]> 0
Syphilis Cases Rise in Canyon County, Greater Southwest District Health Region | Local News Wed, 08 Sep 2021 18:00:00 +0000

]]> 0
There are no midwifery programs in the HCBUs – Quartz Sat, 04 Sep 2021 12:00:32 +0000

The profession of midwifery in the United States is on the rise.

After being relegated to the fringes of childbirth for many decades, midwives are increasingly recognized in the United States. This is in part thanks to an effort to tackle the over-medicalization of childbirth, to help cope with the maternal mortality crisis, as well as to provide a stronger workforce in areas where childbirth is poor. specialists are lacking.

The number of female students enrolled in midwifery programs at U.S. universities has climbed more than 20% since 2015, and the number of midwives has more than doubled since 2010. But a significant subset of the American higher education is lacking: historically black colleges and universities (HCBU).

The midwifery workforce in the United States is not only small, but very homogeneous. More than 90% of the 12,000 midwives in the United States today are white and fewer than 700 are black, says Michelle Drew, midwife and director of Ubuntu, a collective of health and community workers serving of black Delaware families.

This is of particular concern because black women have four times the risk of maternal mortality than white women in the United States, where the rate of pregnancy-related deaths is the highest of any wealthy country. Having more black midwives could encourage black women to seek their services, leading to safer deliveries. Additionally, research has shown that black healthcare providers are associated with better health outcomes for black patients.

The value of midwives

Midwives are health professionals, usually, but not always, nurses, trained to assist women during pregnancy and childbirth. They are not doctors, so they cannot perform emergency medical interventions, such as cesarean sections, but can otherwise replace an obstetrician during an uncomplicated delivery.

There are many valid reasons for promoting births with midwives. They can usually spend more time working with the mother before childbirth, and because they are trained differently from doctors, they are less likely to opt for unnecessary and sometimes risky medical interventions, such as medical induction of labor.

Research has shown that midwives are associated with safer births, and several policy programs and interventions, such as the recent bipartisan Midwifery for Moms Act, presented to Congress in May this year, have sought to develop and diversify the number of midwives.

Yet even with this progress, the United States lags behind peer countries in the number of midwives per capita. In the United States, only 8% of births are attended by a midwife. By comparison, in Europe, more than 75% are, with up to 80% in Germany, 90% in the Netherlands and 98% in France. For every 1,000 live births, countries like Australia and Sweden employ nearly 70 midwives; the United States employs four.

A legacy of discrimination

The story of how American midwives became so small and white begins 100 years ago, with the Sheppard-Towner Act of 1921, a law promoting maternal and child health. Among the provisions of the law was the regulation of midwives, who until then assisted about half of deliveries across the country. Overall, about 90% of black children were delivered by community midwives, says Drew, who has done extensive research on the history of midwifery in the black community.

Although the main culprit in infant mortality was syphilis (penicillin would not be introduced for two decades), the lack of formal training of midwives, who were usually black women, was named as the cause by the architects. of legislation.

When the law was passed, the medical profession was actively trying to discredit midwives. Since the turn of the 20th century, obstetricians and gynecologists have worked to establish their discipline in the United States by presenting pregnancy as a disease and presenting themselves as the doctors to cure it. Professional medical organizations have likened midwives to little more than witchcraft, encouraging women to resort to medical intervention for childbirth, with the aim of harnessing the commercial potential of childbirth.

To professionalize the profession of midwifery and make access more difficult, Sheppard-Towner introduced a requirement that midwives undergo nursing and public health training prior to formal midwifery training.

In less than a decade after the law was passed, the percentage of births attended by midwives fell by 15%, and it is mainly in the segregated South that community midwives have continued to deliver. of African-American babies, although without the current formal training. Required by law.

Obtaining midwifery training was also not easy for those who wanted it. Until the 1940s, only four institutions offered recognized training for nurses to become midwives: the Manhattan School of Midwifery, the Flint-Goodridge School of Nurse-Midwifery in Kentucky, the Catholic Maternity Institute in New Mexico and the Tuskegee School of Nurse-Midwifery. , Alabama.

With the exception of the latter, which was opened at Tuskegee University, an HBCU in 1941, all other programs were officially or de facto off limits to black students. (Prior to Tuskegee’s program, in 1932, Dillard University, an HBCU in Louisiana, opened a midwifery program that never went beyond the first year due to lack of funding.)

In the years that followed, the number of midwives continued to decline and the profession continued to be discredited by the obstetric establishment across the demographics. But black students’ limited access to midwifery training has all but erased their representation in an area that was once a mainstay of the community. And, with the absence of black midwives, black communities have become even less likely to avail themselves of midwifery services.

How to bring midwives to HBCUs

The Tuskegee School of Nurse-Midwifery finally closed in 1945, and although at least two programs have provided training for HCBUs over the years, the last one was discontinued in 2007.

No other HBCU has been able to set up midwifery training since, and the reasons for this struggle “are primarily financial. Midwifery programs are expensive to deliver because they must provide clinical training and the insurance coverage needed to work during childbirth is expensive.

HBCUs often have much smaller endowments than other institutions, and many have been chronically underfunded, causing them to lack the resources to establish an expensive midwifery program, even when they already have health departments. nursing or medicine, as do 39 of them.

Given that 60% of HBCU faculty and the majority of students are black, providing specific funding to set up midwifery programs there would have a dramatic effect on increasing representation in the profession. This in turn could help black communities become familiar with the role of midwifery and not see it as an extravagant novelty in childbirth for the white elite, Drew explains.

But HBCUs not only need the money to set up midwifery programs, they need the support of the institutions that already house them. Beyond the financial resources required, setting up midwifery diplomas is complex and takes time. “If you are considering starting a new program, it will usually take you between two and five years to go through all the administrative tracks of your own institution,” says Monica McLemore, professor of family health nursing at the University of California at San. Francisco.

Once the program is approved within the institution and a first batch of students has graduated, it can apply for the approval of the Accreditation Commission for Midwifery Education, so that its graduates can be admitted to licensing exams. It is a big risk to take, to set up a program and to have the students go through it before even obtaining accreditation.

Some help from non-HCBU friends

To accelerate this, McLemore offers a solution: partnerships. Facilities with established midwifery programs would work with HBCUs, providing support in the design and evaluation of their programs, so that once they are ready for review, accreditation would be faster.

But more fundamentally, McLemore believes existing programs should provide a bridge for HBCU students interested in pursuing midwifery while the programs are implemented in their own institutions. In practice, says McLemore, students at HBCUs would take courses according to the curriculum of another institution offering a midwifery program in the area, and then once the program is in place at their home university, they would resume there. their studies. As the new midwifery program would be implemented with support from the existing program, the transition would be essentially automatic and would not result in any loss of credit for students.

“I submitted [grant proposals] over the past five years of trying to forge links between historically black colleges and universities and universities like mine, ”says McLemore. “Why can’t we facilitate this process so that if we were in partnership, the students could start in our program and end in the new program? “

Unfortunately, obtaining financing remains difficult. Even well-funded universities do not have the resources to fund many new programs, so proposals in this area often compete with others that might be prioritized. Government funding for midwifery education must also cover many areas – and since none are specifically reserved for HBCUs, it tends to go to programs in areas that already have midwifery colleges.

But McLemore sees potential hope in private philanthropy. McKenzie Scott’s recent donations to HCBUs and Native American colleges, ranging from $ 20 million to $ 50 million, have drawn donor attention to the key role of these otherwise neglected institutions. This new focus, along with the actual resources made available through donations, could help, although without the partnership of established institutions the path might remain too difficult for an HBCU to risk substantial funding for it.

]]> 0
Positioning in the sexually transmitted disease (STD) treatment market and growing market share globally Wed, 01 Sep 2021 10:21:48 +0000

The sexually transmitted disease (STD) treatment market is expected to have a very positive outlook for the next eight years 2021-2027. This research report emphasizes on key industry analysis, market size, share, growth, and extended industry dynamics with respect to drivers, opportunities, price details. and the latest industry trends.

The global Sexually Transmitted Disease (STD) Treatment market analysis further provides a pioneering market landscape along with a history of the market rise and key developments involved in the industry. The report also presents a comprehensive research study for professional survey of industries with high growth potential with market analysis. The Sexually Transmitted Disease (STD) Treatment Market report helps companies understand market trends and future market prospects, opportunities, and articulate critical business strategies.

Request a sample copy of the report here

Sexually transmitted diseases (STDs) also called sexually transmitted infections (STIs) or venereal diseases are infections acquired and transmitted from person to person during sexual activity through bodily fluids such as semen, vaginal fluids or the blood. Bacteria, parasites, yeasts and viruses are the causative agents of STDs. Additionally, symptoms seen in patients with STDs include rashes, warts, abdominal pain, or genital ulcers. A physical exam or tests such as ELISA (Enzyme Linked Immunosorbent Assay), a rapid plasma reagent blood test, or an antibody uptake blood test are commonly done to detect STDs.

The growth of the sexually transmitted disease treatment market is attributed to the increasing burden of disease, government initiatives to raise awareness, the growing diagnosis of sexually transmitted diseases, and the increase in the number of products in pipeline by key players in the treatment of STDs.

Sexually Transmitted Disease Treatment Market – Pilot

The increasing burden of sexually transmitted diseases is expected to propel the growth of the sexually transmitted disease treatment market during the forecast period. Among all STDs, the most common STDs include gonorrhea, chlamydia, syphilis, herpes, hepatitis (HBV), and human immunodeficiency virus (HIV). For example, according to the Centers for Disease Control and Prevention (CDC), in 2016, 1,598,354 cases of Chlamydia trachomatis infection were reported in the United States, corresponding to 497.3 cases per 100,000 in 2015. Additionally , 468,514 cases of gonorrhea were reported for a rate of 145.8 cases per 100,000 inhabitants, an increase of 18.5% compared to 2015. Unprotected sexual practice is one of the main factors of the increased incidence of STDs, which in turn stimulates demand for STD treatment. For example, according to the World Health Organization (WHO), unprotected sex is the second most common risk factor for increased disease burden.

The number of products under development for the treatment of HIV is high, which is expected to fuel the growth of the sexually transmitted disease treatment market during the forecast period. For example, in 2017, GSK and ViiV Healthcare filed an application with the European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) for regulatory affiliation of a single tablet to two medicines based on dolutegravir (by ViiV Healthcare) and rilpivirine. (by Janssen) indicated for the treatment of HIV-1 infection. In addition, other drug candidates in development include – PrEP, PRO140 with ibalizumab, BMS-955176, which are expected to be launched during the forecast period. In addition, governments are focusing on funding research and development programs, which is expected to drive the growth of the market. For example, the British Columbia Center for Disease Control sponsored studies of the drug doxycycline for the indication of syphilis and other sexually transmitted infections, which is in the early stages of the clinical trial of phase I, from 2016.

In addition, the increase in government initiatives to raise awareness of STDs through campaigns and free diagnostic camps is also expected to propel the growth of the sexually transmitted disease treatment market during the forecast period. For example, the Centers for Disease Control and Prevention (CDC) in 2014 launched improving sexually transmitted disease programs through assessment, assurance, policy development and prevention. , or STD-AAPPS. Additionally, in 2018, Thunder Bay Group — HIV / AIDS / Hepatitis C Education and Support Provider, expanded access to hepatitis C medications for people with hepatitis C. level 2, after negotiating with the provinces and drug manufacturers.

However, low disease detection rate and late diagnosis of disease like HIV are the factors which are expected to hamper the growth of the sexually transmitted disease treatment market during the forecast period.

Sexually Transmitted Disease Treatment Market – Regional Analysis

On the basis of region, the sexually transmitted disease treatment market is segmented into North America, Latin America, Europe, Asia-Pacific, Middle East and Africa. Among the regions, North America is expected to hold a dominant position in the market during the forecast period, owing to increasing government initiatives for disease awareness and implementation of prenatal screening programs.

In addition, Asia-Pacific is expected to be the fastest growing market in the treatment of sexually transmitted diseases, due to the high incidence of sexually transmitted infections due to unsafe sex practices in the region. For example, according to the Joint United Nations Program on HIV and AIDS (UNAIDS), Asia-Pacific had the second highest number of people living with HIV globally, at 5.1 million, in 2016. In addition, Asia-Pacific countries like China, India and Indonesia account for three quarters of the total people living with HIV.

Purchase this report with a flat rate US $ 2000 discount –

Sexually Transmitted Disease (STD) Treatment Market – Competitive Landscape

The major players operating in the global prosthetic sleeves market are as follows: Merck & Co. Inc., Pfizer INC, GlaxoSmithKline Plc, Vertex Pharmaceuticals, Roche, Gilead Sciences Inc., AbbVie Inc., Johnson & Johnson and Bristol-Myers Squibb.

Key Highlights of the Sexually Transmitted Disease (STD) Treatment Market Report Table of Contents

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Scope of the research
1.4 Market Analysis by Regions
1.5 Global Sexually Transmitted Disease (STD) Treatment Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Impact on the Sexually Transmitted Disease (STD) Treatment Industry

Chapter 2 Global Sexually Transmitted Disease (STD) Treatment Competition by Types, Applications and Major Regions and Countries
2.1 Global Sexually Transmitted Disease (STD) Treatment (Volume & Value) by Type
2.3 Global Sexually Transmitted Disease (STD) Treatment (Volume & Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional production market analysis

Chapter 4 Global Sexually Transmitted Disease (STD) Treatment Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Sexually Transmitted Disease (STD) Treatment Market Analysis
Chapter 6 East Asia Sexually Transmitted Disease (STD) Treatment Market Analysis
Chapter 7 Europe Sexually Transmitted Disease (STD) Treatment Market Analysis
Chapter 8 South Asia Sexually Transmitted Disease (STD) Treatment Market Analysis
Chapter 9 Southeast Asia Sexually Transmitted Disease (STD) Treatment Market Analysis
Chapter 10 Middle East Sexually Transmitted Disease (STD) Treatment Market Analysis
Chapter 11 Africa Sexually Transmitted Disease (STD) Treatment Market Analysis
Chapter 12 Oceania Sexually Transmitted Disease (STD) Treatment Market Analysis
Chapter 13 South America Sexually Transmitted Disease (STD) Treatment Market Analysis
Chapter 14 Company Profiles and Key Figures of the Sexually Transmitted Disease (STD) Treatment Industry
Chapter 15 Global Sexually Transmitted Disease (STD) Treatment Market Forecast (2021-2027)
Chapter 16 Conclusion
Research methodology

About Coherent Market Insights

Coherent Market Insights is a leading market research and consulting firm providing action-ready syndicated research reports, personalized market analysis, advisory services and competitive analysis through various recommendations related to emerging market trends , technologies and potential opportunities in absolute dollars.

Contact us

Mr. Shah
Consistent market information
1001 4th avenue, # 3200
Seattle, Washington 98154
Phone: United States +12067016702 / United Kingdom +4402081334027

]]> 0
Sexually Transmitted Disease (STD) Diagnostics Market Expected to Experience Amazing Growth by 2027 | Abbott, Roche, Thermo Fisher Scientific Sun, 22 Aug 2021 10:59:32 +0000

Sexually Transmitted Disease (STD) Diagnostics Market research is an intelligence report with meticulous efforts undertaken to study accurate and valuable information. The data that has been examined is done taking into account both the best existing players and the future competitors. The business strategies of major players and new industries entering the market are studied in detail. A well explained SWOT analysis, revenue share and contact details are shared in this report analysis. It also provides information on the market in terms of development and its capabilities.

The sexually transmitted disease (STD) diagnostics market is growing at a high CAGR during the forecast period 2021-2027. The growing interest of individuals in this industry is the main reason for the expansion of this market.

Get a sample report with the latest analysis of industry trends:

Some of the best companies influencing this market include: Abbott, Roche, Thermo Fisher Scientific, Aposcience, BCR Diagnostics, BD Medical, Biocartis, BioMérieux, Bio-Rad, Cepheid, Danaher, DiaSorin, Quidel, GenMark Diagnostics, Hologic, OraSure Technologies, Qualigen.

Various factors are responsible for the growth trajectory of the market, which are discussed at length in the report. Further, the report lists restraints that pose threat to the global sexually transmitted disease (STD) diagnostics market. It also assesses the bargaining power of suppliers and buyers, the threat of new entrants and substitutes, and the degree of competition prevailing in the market. The influence of the latest government directives is also analyzed in detail in the report. It studies the trajectory of the Sexually Transmitted Disease (STD) Diagnostics market between forecast periods.

Global Segmentation of the Sexually Transmitted Disease (STD) Diagnosis Market:

Segment by type

Chlamydia Screening, Syphilis Screening, Gonorrhea Screening, Herpes Simplex Virus Screening, Human Papillomavirus Screening, Human Immunodeficiency Virus Screening

Segment by application

Government agencies, Hospitals, Diagnostic clinics

Global Sexually Transmitted Disease (STD) Diagnostics Market Report Offerings:

  • Market definition of the global sexually transmitted disease (STD) diagnostics market along with the analysis of different influencing factors such as drivers, restraints, and opportunities.
  • In-depth research on the competitive landscape of global sexually transmitted disease (STD) diagnostics
  • Identification and analysis of the micro and macro factors that have and will affect the growth of the market.
  • A comprehensive listing of major market players operating in the global Sexually Transmitted Disease (STD) Diagnostics Market.
  • Analysis of different market segments such as type, size, applications and end users.
  • It offers a descriptive analysis of the supply-demand chaining in the global sexually transmitted disease (STD) diagnostics market.
  • Statistical analysis of some significant economic facts
  • Figures, tables, graphs, images to clearly describe the market.

Get the personalization on this report:

Regions Covered by the Global Sexually Transmitted Disease (STD) Diagnostics Market Report 2021:
The Middle East and Africa (GCC countries and Egypt)
North America (United States, Mexico and Canada)
South America (Brazil etc …)
Europe (Turkey, Germany, Russia UK, Italy, France, etc.)
Asia Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia and Australia)

The cost analysis of the global Sexually Transmitted Disease (STD) Diagnostics market has been performed keeping in view the manufacturing expense, cost of labor and raw materials, along with their market concentration rate , their suppliers and price trends. Other factors such as supply chain, downstream buyers, and sourcing strategy were assessed to provide a complete and in-depth view of the market. Buyers of the report will also be exposed to a market positioning study with factors like target customer, branding, and pricing taken into account.

The key questions the report answers:

  • What will the market size and growth rate be by the end of the forecast period?
  • What are the key trends in the Sexually Transmitted Disease (STD) Diagnostics market impacting the market growth?
  • What are the potential growth opportunities and threats faced by the major competitors in the market?
  • What are the key findings of Porter’s five forces analysis and SWOT analysis of major players operating in the global Sexually Transmitted Disease (STD) Diagnostics Market?
  • This report gives all the information regarding industry overview, analysis, and revenue for this market.
  • What are the market opportunities and threats faced by the vendors in the global Sexually Transmitted Disease (STD) Diagnostics Market?

Table of Contents (TOC)

Global Sexually Transmitted Disease (STD) Diagnostics Market Report 2021 – Growth, Trend and Forecast Till 2027

Chapter 1 Sexually Transmitted Disease (STD) Diagnostics Market Overview

Chapter 2 Global Economic Impact on Sexually Transmitted Disease (STD) Diagnostics Industry

Chapter 3 Global Sexually Transmitted Disease (STD) Diagnostics Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region (2014-2021)

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions (2014-2021)

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Analysis of Manufacturing Costs

Chapter 9 Industry Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors / Traders

Chapter 11 Analysis of Market Effect Factors

Chapter 12 Global Sexually Transmitted Disease (STD) Diagnostics Market Forecast (2021-2027)

Chapter 13 Appendix

Buy an exclusive report:

Contact us:

Roger smith


[email protected]

+1 775 237 4147

Global Resveratrol Market Report 2021 Size, Share, Growth and Forecast to 2028

]]> 0
Current and Future Size of the Chlamydia Infections Diagnostics Market | BD Medical, Bio Rad Laboratories, Novartis AG Sun, 22 Aug 2021 10:29:24 +0000

A2Z Market Research announces the release of Chlamydia Infections Diagnostics Market research report. The market is expected to grow at a sustained rate in the coming years. The 2021 Chlamydia Infections Diagnostics Market Research Report presents an analysis of the market size, share and growth, trends, cost structure, statistical and comprehensive data of the global market. The report gives a clear picture of the current market situation. It includes the digital wallpaper of historical and technological advent, macroeconomic and driving factors and assesses the market size in terms of value and volume, in the market.

Get a sample report with the latest analysis of industry trends:

Key companies in this report are: BD Medical, Bio Rad Laboratories, Novartis AG, F Hoffmann-La Roche, Abbott Laboratories, Danaher Corporation, BioMérieux, DiaSorin SpA, Siemens AG, Thermo Fisher Scientific.

As analytics has become an inherent part of every business activity and role, a central role in the decision-making process of businesses today is mentioned in this report. Over the next few years, the demand for the market is expected to increase significantly globally, enabling healthy growth of the Chlamydia Infection Diagnostics market is also detailed in the report. This report highlights the manufacturing cost structure which includes cost of materials, cost of labor, depreciation cost, and cost of manufacturing procedures. Price analysis and equipment supplier analysis is also performed by analysts in the report.

This research report represents a 360-degree overview of the competitive landscape of the Employee Protection Software Market. In addition, it offers massive data relating to recent trends, technological advancements, tools and methodologies. The research report analyzes the Employee Protection Software market in a detailed and concise manner for a better understanding of businesses.

The report, using detailed business profiles, project feasibility analysis, SWOT review, and a few different insights of key organizations working in the Chlamydia Infection Diagnostics Market, presents a point-by-point scientific record competitive market scenario point. The report also presents a review of the effect of recent market developments on the future development prospects of the market.

Market segmentation

Segment by type

Nucleic acid amplification assays (NAAT), direct fluorescence assays, others

Segment by application

Hospitals, Specialized clinics, Diagnostic centers

Get the personalization on this report:

Geographic analysis

The global Chlamydia Infection Diagnostics market is spread across North America, Europe, Asia Pacific, Middle East & Africa as well as the rest of the world.

COVID-19 impact assessment

The COVID-19 pandemic has emerged in containment across regions, line limitations and the breakdown of transport organizations. In addition, the financial vulnerability of the Chlamydia infection diagnostics market is much higher than past outbreaks like extreme intense respiratory state (SARS), avian influenza, swine flu, avian influenza and Ebola, inferred from the increasing number of infected individuals and vulnerability on the end of the crisis. With the rapid increase in cases, the global market for refreshments for diagnosis of Chlamydia infections is influenced from several points of view.

Accessibility of workforce is obviously disrupting the inventory network of the global Chlamydia Infection Diagnostics beverage market as the lockdown and spread of infection causes individuals to stay indoors. The presentation of the manufacturers of Chlamydia Infection Diagnostics and the transport of the products are associated. If the assembly movement is stopped, the transport as well as the warehouse network also stop. Stacking and dumping of items i.e. raw materials and results (fasteners), which requires a ton of labor, is also heavily affected due to the pandemic. From the entrance of the assembly plant to the warehouse or distribution center to end customers, i.e. application companies, the entire inventory network of Chlamydia Infection Diagnostics is severely compromised due to the episode.

The research provides answers to the following key questions:

  • What is the projected market size of the Chlamydia Infection Diagnostics market by 2027?
  • What will the normal share of the industry as a whole be for the years to come?
  • What are the major components and restraints in the development of the Global Chlamydia Infections Diagnostics Market across varying geographies?
  • Who are the major sellers expected to dominate the market for the 2021 to 2027 evaluation period?
  • What are the moving and upcoming advancements expected to influence the advancement of the global Chlamydia Infection Diagnostics Market?
  • What are the development techniques received by major market sellers to stay ahead of the curve?

Buy an exclusive report:

Contact us:

Roger smith


[email protected]

+1 775 237 4147

Global Distributed Temperature Sensing (DTS) Market Report 2021 Size, Share, Growth and Forecast to 2028

]]> 0
Syphilis Rapid Test Kits Consumption Market Size, Analysis, and Major Suppliers – Abbott (Alere), Bio-Rad ?, WanTai BioPharm, Beckman Coulter, BD, Kehua, Livzon ?, Intec, ThermoFisher Sun, 22 Aug 2021 06:12:26 +0000

New Jersey, United States, – The Syphilis Rapid Test Kits Consumption Market Size and forecast to 2028, this report provides an analysis of the impact of the COVID19 epidemic on the key points influencing the growth of the market. Also, the Consumption Market Segments of the Syphilis Rapid Test Kits (by major players, types, applications and major regions) outlook, business valuation, competitive scenario, trends and forecasts for the coming years. The study of the consumption report of the rapid syphilis test kit is carried out on the basis of a substantial research methodology, which enables analytical inspection of the global market by means of different segments in which the industry is also alienated in summary, an increase in the size of the market due to the different possibilities of prospects. The report also gives a 360-degree view of the competitive landscape industries. SWOT analysis has been used to understand the strengths, weaknesses, opportunities and threats of businesses. This will help businesses understand the threats and challenges they face. The Syphilis Rapid Test Kits consumption market shows steady growth and the CAGR is expected to improve during the forecast period.

Get | Download a sample copy @

The report provides a detailed analysis of the major market players along with an overview of their business, expansion plans, and strategies. The main players examined in the report are:

  • Abbott (Alère)
  • Bio-Rad?
  • WanTai BioPharm
  • Beckman coulter
  • Comics
  • Kehua
  • Livzon?
  • Intec
  • ThermoFisher
  • Biokit
  • Nectar Life Sciences
  • ELITech Group
  • Chembio diagnostic systems
  • Trinity Biotech

This report provides in-depth analysis of Syphilis Rapid Test Kit consumption, current trends, along with comprehensive analysis based on type, application, and players. The report includes detailed analysis of competitors, SWOT analysis, industry structure and production process view. The report explains that the market for the consumption of rapid syphilis test kits is fueled by several factors. This study underlines how important it is to carry out in-depth analyzes and how much this has a strong impact on the quality of the information made available to readers. Further, the report examines the impact on the Consumption of COVID-19 Pandemic Syphilis Rapid Test Kits market and provides a clear assessment of market trends for the forecast period.

The report further studies the market segmentation on the basis of the types of products offered in the market and their end uses.

While segmenting the market by types of Syphilis Rapid Test Kits consumption, the report includes:

  • Serum test
  • Direct bacteria test

While segmenting the market by Consumption Applications of Syphilis Rapid Test Kits, the report covers the following application areas:

  • Diagnostic centers
  • Hospitals
  • Home use

Request a discount @

Scope of Syphilis Rapid Test Kits Consumption Market Report

Report attribute Details
Market size available for years 2021 – 2028
Reference year considered 2021
Historical data 2015 – 2019
Forecast period 2021 – 2028
Quantitative units Revenue in millions of USD and CAGR from 2021 to 2028
Covered segments Types, applications, end users, etc.
Cover of the report Revenue forecast, company ranking, competitive landscape, growth factors and trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free customization of the report (equivalent to up to 8 working days for analysts) with purchase. Add or change the scope of country, region and segment.
Price and purchase options Take advantage of personalized shopping options to meet your exact research needs. Explore purchasing options

Due to regional segmentation, the market is divided into major regions North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. Further, the regional analysis covers the market split and major players by country.

The research report offered by Market Research Intellect provides an updated view of the global Syphilis Rapid Test Kits Consumption market. The report provides a detailed analysis of key trends and emerging market factors that might affect the growth of the industry. Additionally, the report studies the market characteristics, competitive landscape, market size and growth, regional breakdown, and strategies for this market.

Highlights of Syphilis Rapid Test Kit Consumption Report Content:

?? Global Syphilis Rapid Test Kit Consumption Market Analysis

➮ Competition in the market of players and manufacturers

competitive environment

Production, sales estimate by type and application

➮ Regional analysis

➮ Industrial chain analysis

➮ Global Syphilis Rapid Test Kit Consumption Market Forecast

For more information, please visit us @

Visualize the Syphilis Rapid Test Kits Consumption Market Using Verified Market Intelligence: –

Verified Market Intelligence is our BI platform for narrative storytelling for this market. VMI offers in-depth forecasting trends and accurate insight into over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a holistic overview and global competitive landscape with regard to region, country, segment and key players in your market. Present your market report and findings with the built-in presentation function, saving over 70% of your time and resources for investor arguments, sales and marketing, R&D and product development. VMI enables data delivery in interactive Excel and PDF formats with over 15+ key market indicators for your market.

Visualize the Syphilis Rapid Test Kits Consumption Market Using VMI @

Thanks for reading our report. The report can be customized according to chapters or regions. Contact us to learn more about the customization options and our team will make sure that you generate a report based on your needs.

About Us: Market Research Intelligence

Market Research Intellect provides syndicated and personalized research reports to clients across various industries and organizations with the goal of delivering personalized and in-depth research studies.

Our advanced analytical research solutions, personalized advice and in-depth data analytics span a wide range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and drinks. Etc

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable information without compromise.

After serving over 5,000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

Contact us:

Mr. Edwyne Fernandes

Market research intelligence

United States: +1 (650) -781-480
UK: +44 (753) -715-0008
APAC: +61 (488) -85-9400
US Toll Free: +1 (800) -782-1768

Website –

]]> 0
3 Penny Stocks on Robinhood to Watch Before End of August Sun, 08 Aug 2021 19:00:00 +0000

August 8, 2021

6 minutes to read

This story originally appeared on PennyStocks

Are These Biotech Penny Stocks Worth Watching Right Now?

There’s a reason biotech penny stocks have remained so popular among investors this year. And while Covid was initially the main cause of increased investor interest, its lasting effect has helped attract large numbers of traders to the biotech industry.

A year and a half ago, investors were looking for biotech penny stocks that could benefit from Covid. This made sense as the pandemic was only just beginning and companies involved in vaccines or treatments were skyrocketing in value. However, as time passed and the focus on biotechnology continued to grow, more and more companies began to show potential.

[Read More] Are Penny Stocks Worth It? 5 that deserve your attention now

Today, in August, there are hundreds of biotech stocks to choose from, all with different value points for investors to consider. As always, traders should do as much research as possible to make sure they know exactly what they are getting into. But, with the Internet at your fingertips, research is easier than ever. On top of that, apps like Robinhood have made it much easier to trade penny stocks. With that in mind, here are some biotech stocks that could be on the watchlist before the end of the month.

3 Biotech Penny Stocks To Watch Right Now

  1. ReShape Lifesciences Inc. (NASDAQ: RSLS)
  2. Asensus Surgical Inc. (NYSE: ASXC)
  3. Chembio Diagnostics Inc. (NASDAQ: CEMI)

ReShape Lifesciences Inc. (NASDAQ: RSLS)

ReShape Lifesciences Inc. is a biotech penny stock that we have covered several times over the past few months. This company sells products for the treatment of obesity and for the resolution of metabolic diseases. Its various products include the Lap-Band System, ReShapeCare, ReShape Diabetes Bloc-Stim Neuromodulation, and more.

Read more

These products have become extremely popular in the weight loss industry and have attracted the attention of investors to RSLS stocks. On August 5, the company released its preliminary unaudited financial results for the second quarter of 2021. The company’s revenue increased 107% year-over-year during this period.

“The second quarter was exceptional for the Company. During this period, we completed our highly anticipated merger with Obalon Therapeutics, increased our visibility in financial markets by listing on Nasdaq, and strengthened our diverse product portfolio with the launch of our online wellness center, ReShape. MarketPlace.

RSLS President and CEO Bart Bandy

This massive increase in income is a reflection of increased demand for ReShape’s products. Additionally, elective procedures began to occur at levels similar to those before covid. On the day of the press release, RSLS stock rose more than 7%. So, given all of this, will RSLS make your list of penny stocks to watch?

Asensus Surgical Inc. (NYSE: ASXC)

Asensus Surgical Inc. is another biotech penny stock that we have frequently covered over the past few months. It is a company that creates medical devices in the United States, Asia and Europe. Asensus researches, develops and sells robotic medical devices for surgical purposes.

Its products include the Senhance Surgical System, which is a multi-port robotic surgery system allowing up to four arms to control robotic instruments and a camera. One of the main reasons investors watch ASXC is for its innovations in the surgical industry. Asensus creates these proprietary products that can be used to improve many common surgical procedures. On August 5, the company released its operating and financial results for the second quarter of 2021.

“During the quarter, we continued to generate strong adoption and usage trends while advancing towards our strategic focus areas including expanding clinical evidence, growing our installed base, increasing procedural volumes, the expansion of our portfolio and the pursuit of technological development. by Senhance.

Asensus Surgical President and CEO Anthony Fernando

In the first half of 2021, the company signed two lease agreements with hospitals to install its Senhance surgical systems. He also noted that more than 1,000 procedures have been performed using this technology in the first half of 2021. ASXC stock rose more than 2% on the day of this release. Given this information, is ASXC a competitor for your list of penny stocks to watch?


Chembio Diagnostics Inc. (NASDAQ: CEMI)

Since July 20, CEMI shares have jumped more than 40%. This is a huge gain in a short time, and shows just how much potential CEMI could have. In a certain context, Chembio is a company that currently offers test kits for COVID-19 as well as tests for HIV, syphilis and Zika virus.

The Company’s products are sold under the SURE CHECK, STAT VIEW, DPP and STAT-PAK brands. While its Covid-19 product shows short-term potential for the company, its other products could help it achieve long-term success. In addition, the diseases it offers testing for are all very common around the world, indicating strong market demand for its products in the future.

[Read More] Why Penny Stocks investors are bullish on these 3 small caps

On August 5, Chembio Diagnostics released its second quarter financial results for 2021. The company’s total revenue for the quarter increased 26% year-over-year. In addition to this positive news, the turnover of its products also increased by 4% year on year. During the quarter, Chembio mainly focused on its DPP COVID testing.

“In the second quarter, we focused on international business opportunities where our DPP COVID test was approved. These efforts were successful, resulting in the largest order in company history for DPP SARS-CoV-2 antigen testing from our long-time customer Bio-Manguinhos. We have also made progress in our clinical activity to support US regulatory submissions for our DPP COVID-19 tests. ”

President and CEO of Chembio Diagnostics, Richard Eberly

Given this exciting news and the potential the CEMI stock could have, is it worth adding it to your watchlist?


Which Biotech Penny Stocks Are Worth Buying?

Finding the best biotech penny stocks to buy is all about figuring out where to look. With so many to choose from, investors should narrow down the list by looking at a company’s financial data, pipeline, and any other information it publishes. Given all of this, what penny stocks in the biotech industry are you seeing right now?

]]> 0
STD Diagnostics market study including growth factors, new key players, competitive analysis by regions from 2021 to 2028 Fri, 06 Aug 2021 18:25:18 +0000

The STD Diagnostics market research report has been organized with the most advanced information and analysis to provide maximum benefit to the industry. The report can be used by established and new industry players for a complete understanding of the market. In addition, this marketing report also includes historical data, current and future market trends, environment, technological innovation, upcoming technologies, and technical advancements in the related industry. The scope of an excellent STD Diagnostics market report includes industry research, customer insights, market size and forecast, competitive analysis, market entry strategy, trends pricing, sustainability trends, innovation trends, technological developments and an assessment of distribution channels.

The global STD diagnostics market is expected to grow at a CAGR of 18.95% during the forecast period 2019-2026. This increase in market value can be attributed to the increased prevalence rates of STDs.

Get a sample report + all related charts and graphs @

Key Market Competitors: Global STD Diagnostics Market

Few of the major competitors currently working in the STD diagnostics market are Abbott, aposcience, BD, Biocartis, bioMérieux SA, Bio-Rad Laboratories, Inc, Cepheid, Danaher, DiaSorin, GenMark Diagnostics, Inc., Hologic Inc., OraSure Technologies , Inc., Qualigen Inc, Quidel Corporation, F. Hoffmann-La Roche Ltd and Thermo Fisher Scientific Inc, Hologic Inc, MedMira Inc.

All the data, statistics, and information composed in the winning STD Diagnostics Market report have been researched and analyzed with the demonstrated tools and techniques such as SWOT Analysis and Porter’s Five Forces Analysis. This industry report provides an in-depth overview of the product specification, technology, product type, and production analysis taking into account key factors such as revenue, cost, and gross margin. This market report acts on the systematic collection, recording, and analysis of data for concerns related to marketing of goods and services and thus serves the industry as an excellent market research report. Granular market insights assembled in the top-notch STD Diagnostics Market report will be helpful for the industry to make competent business decisions.

Competitive Analysis: Global STD Diagnostics Market

The global STD diagnostics market is highly fragmented and major players have used various strategies such as new product launches, extensions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprint in this market. The report includes the market share of the STD diagnostics market for the world, Europe, North America, Asia-Pacific, South America, Middle East & Africa.

Brief description:-

Global STD Diagnostics Market by Type (Chlamydia Test, Syphilis Test, Gonorrhea Test, Herpes Simplex Virus Test, Human Papillomavirus Test, Human Immunodeficiency Virus Test), tests (laboratory devices, point-of-care devices), test devices (thermal cyclers, PCR, Lateral flow readers – Immunochromatographic assays, Flow cytometers, Differential light scattering machines, Absorbance microplate reader, Chips Phones, Rapid Diagnostic Kits), End User (Hospitals, Others), Geography (North America, South America, Europe, Asia Pacific, Middle East & Africa) Industry Trends and Forecasts to 2026

Market factors:

  • The implementation of national screening programs stimulates the market.
  • The growing incidence of STDs is driving the market.

Market restriction:

  • The high cost of advanced diagnostic devices restricts the market.

Purpose of the report:

The report strives to provide all the insights on the STD Diagnostics market along with all the CAGR values ​​and market share analysis of all market players. The report is vital market information which explains entire competitive landscape and all market segments while analyzing and forecasting the STD Diagnostics market for the years to come. The report also provides all the details in terms of recent developments in the market and all manufacturers.

Key developments in the market:

  • In November 2017, uBiome announced the launch of the new SmartJane Women’s Health Test to check 23 vaginal flora as well as 19 strains of the human papillomavirus and a range of sexually transmitted diseases like chlamydia and gonorrhea in the home. It can be ordered online and sent to a certified lab for results. The main goal is to encourage women to get tested for certain life-threatening STIs such as HPV.
  • In December 2016, Roche announced the launch of its cobas CT / NG on the cobas 6800/8800 systems or the direct detection of DNA from Chlamydia trachomatis (CT) and / or Neisseria gonorrhoeae (NG) in symptomatic individuals and asymptomatic. They deliver results in dramatically reduced time and are a fully integrated, automated solution that will set a new standard for routine molecular testing.

Table of Contents: STD Diagnostics Market

Part 01: executive summary
Part 02: Scope of the report
Part 03: STD Diagnostics Market
Part 04: Sizing the Global STD Diagnostics Market
Part 05: Global STD Diagnostics Market Segmentation By Product
Part 06: Five Forces Analysis
Part 07: Client landscape
Part 08: Geographical landscape
Part 09: Decision framework
Part 10: Drivers and challenges
Part 11: Market trends
Part 12: Supplier landscape
Part 13: Supplier analysis

Complete Report Details with Facts and Figures along with Respective Images and Charts (TOC) @

The STD Diagnostics market research report includes in-depth research on current industry conditions, market potential in the present, and future prospects. Moreover, this report also includes details on market analysis, market definition, market segmentation, key development areas, competitive analysis, and research methodology. This market report also covers a very important aspect which is competitive intelligence and through this, companies can gain competitive advantage to thrive in the market. Only genuine market analysis tools are used that businesses can trust with confidence.

Key points of the report:

  • Historical and current market size and projection to 2027
  • Market trends impacting the growth of the Global Taste Modulator Market
  • Analyze and forecast the Taste Modulator market based on application and type.
  • Trends in key regional and national markets for processes, derivatives and applications
  • Company profiling of key players which includes business operations, products and services, geographic presence, recent developments and key financial analysis

About the Data Bridges Market Research:

An absolute way to predict what the future holds is to understand the trend today!
Data Bridge has established itself as an unconventional, neoteric market research and consulting company with an unprecedented level of resilience and integrated approaches. We are committed to finding the best market opportunities and promoting effective information for your business to thrive in the market. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process.


Market research on data bridges

United States: +1 888 387 2818

UK: +44 208 089 1725

Hong-Kong: +852 8192 7475

Email @

]]> 0